Mammary Tumors in Cats: Risks, Signs & Treatment
Understanding feline mammary tumors: causes, symptoms, diagnosis, and treatment options for cat owners.

Understanding Mammary Tumors in Cats
Mammary tumors represent one of the most common types of cancer that develop in cats, particularly affecting intact female cats. These abnormal growths arise from the breast tissue and can vary significantly in their behavior and prognosis. Understanding this condition is crucial for cat owners, as early detection and intervention can dramatically improve survival outcomes. This comprehensive guide provides essential information about mammary tumors in cats, helping pet owners recognize warning signs and make informed decisions about their feline companion’s health.
What Are Mammary Tumors?
Mammary tumors are abnormal growths that develop in the mammary glands, which are the breast tissue responsible for producing milk in female cats. These tumors develop from cells within the mammary tissue and can be either benign (noncancerous) or malignant (cancerous). The critical distinction between benign and malignant tumors lies in their ability to spread to other parts of the body—a process called metastasis.
In cats, the vast majority of mammary tumors are malignant, with studies showing that between 80% and 96% of mammary tumors in cats are cancerous. This contrasts sharply with dogs, where approximately 50% of mammary tumors are benign. The high malignancy rate in cats makes early detection and aggressive treatment particularly important for improving outcomes.
Types of Mammary Tumors
Several different types of mammary tumors can develop in cats, with carcinomas being the most common category. Carcinomas originate from the epithelial cells that line the mammary ducts and glands. The most frequently encountered subtypes include:
– Simple tubular carcinomas- Tubulopapillary carcinomas- Solid carcinomas- Cribriform carcinomas- Mucinous carcinomas
While less common, other malignant tumors can also affect the mammary glands, including osteosarcomas and squamous cell carcinomas. Additionally, cats can develop multiple mammary tumors simultaneously, with some individuals developing different tumor types in various glands.
Risk Factors for Mammary Tumors in Cats
Hormone Status and Spaying
The most significant risk factor for developing mammary tumors in cats is hormone exposure, particularly estrogen and progesterone. Sexually intact female cats have a dramatically elevated risk compared to spayed cats. Research demonstrates that intact cats have a seven-fold increased risk of developing mammary tumors compared to spayed cats.
The timing of spaying is critically important for cancer prevention. Cats spayed before six months of age have only a 9% risk of developing mammary tumors during their lifetime, representing a 91% decreased risk compared to intact cats. When spaying is performed between seven and twelve months, the protective benefit remains substantial, with a 14% risk of mammary tumor development, representing an 86% decreased risk. However, the protective effect of ovariohysterectomy diminishes significantly as cats age, with spaying providing no benefit after two years of age.
Exogenous Hormones
Administration of exogenous progestins (synthetic hormones) can increase the risk of mammary tumor development in both male and female cats. Additionally, the use of combination estrogen-progestin treatments is associated with a three-fold increased risk of developing either benign or malignant mammary tumors. Cat owners should discuss the risks and benefits of hormonal treatments with their veterinarian.
Age and Sex
Mammary tumors typically develop in older female cats, with the average age of diagnosis being over ten years. Male cats rarely develop mammary tumors, though it is possible in intact males or those exposed to exogenous hormones.
Clinical Signs and Symptoms
Recognizing the clinical signs of mammary tumors is essential for early detection. Many cats show no obvious symptoms in the early stages, making regular physical examination crucial. Common clinical findings include:
– A palpable mass or lump under the skin of the abdomen or near a nipple- Firm, irregular nodules in the mammary tissue- Redness or swelling of the nipples- Discharge from the nipples (often tan to yellow fluid)- Ulceration or skin changes over the tumor- Firm adherence of the mass to overlying skin- Swelling or enlargement of regional lymph nodes
It is important to note that cats have four pairs of mammary glands, and tumors can develop in any of these glands. Some reports suggest that the caudal (rear) mammary glands are more commonly affected, though this has not been definitively established. Because cats frequently develop multiple mammary tumors, all four pairs of mammary glands should be carefully examined by a veterinarian during the physical examination.
Diagnosis of Mammary Tumors
Physical Examination
The diagnostic process begins with a thorough physical examination. Your veterinarian will carefully palpate all four pairs of mammary glands to identify any masses or abnormalities. Any suspicious lumps will be noted for further investigation.
Biopsy and Histopathology
A biopsy is the most reliable method to distinguish between benign and malignant masses and to determine the specific type of tumor present. During a biopsy, a small sample of tissue is collected from the suspicious mass and examined under a microscope by a pathologist. This examination allows for classification of the tumor type and assignment of a tumor grade.
Tumor Grading
Once histological results are available, feline mammary carcinomas can be graded using the Elston and Ellis grading system, which evaluates tissue differentiation, nuclear pleomorphism (variation in cell shape and size), and mitotic count (the number of cells actively dividing). Higher tumor grades are associated with poorer prognosis, with grade III carcinomas showing significantly shorter median survival times compared to grade I tumors.
Staging and Metastatic Workup
Clinical staging is recommended before treatment begins to determine the extent of disease and establish accurate prognosis. The staging system most commonly applied to cats is adapted from the WHO staging system and is based on tumor size:
– Stage I: Primary tumor less than 2 centimeters- Stage II: Primary tumor 2 to 3 centimeters- Stage III: Primary tumor greater than 3 centimeters, or any tumor with lymph node involvement- Stage IV: Any tumor with distant metastasis
Evaluation of the primary tumor’s diameter is particularly helpful in establishing prognosis, as larger tumors (greater than 3 centimeters) carry a significantly worse prognosis than smaller tumors.
The metastatic workup includes:
– Complete blood count- Serum chemistry panel- Urinalysis- Fine needle aspiration of local drainage lymph nodes- Chest X-rays to evaluate for pulmonary metastasis- Abdominal ultrasound to assess for internal organ involvement
Lymph node involvement is a critical prognostic factor. More than a quarter of cats have regional lymph node metastasis at the time of initial diagnosis. The axillary and inguinal lymph nodes are most commonly affected, though the sternal lymph node may also be involved in approximately 30% of cases.
Prognosis and Prognostic Factors
Impact of Tumor Size
Tumor size is one of the most important determinants of prognosis. If caught early when tumors are smaller than two centimeters in diameter, survival chances are very good, with many cats surviving three years or more after treatment. Conversely, cats with stage IV disease (distant metastasis) exhibit notably short median survival times of approximately 44 days.
Lymph Node Metastasis
Lymph node metastasis represents a significant adverse prognostic factor. Research has consistently shown that all cats with lymph node metastasis at the time of surgery developed progressive disease within eight months, highlighting the predictive value of this finding. However, bilateral mastectomy demonstrated protective effects against disease progression even in cases with metastatic lymph nodes, suggesting a positive impact of surgical approach on prognosis.
Other Prognostic Indicators
Additional factors influencing prognosis include the location of metastasis, with cats having nodal, pulmonary, and pleural metastasis exhibiting progressively worse median survival times. High proliferation indices, as measured by Ki-67 staining, are associated with decreased survival, with cats showing high proliferative activity having only a 12% survival rate at 12 months compared to 88% in those with low proliferative indices.
Treatment Options
Surgical Excision
Surgical excision is the treatment of choice for feline mammary tumors. When tissue involvement is confined to the mammary glands, mastectomy is performed to remove the affected mammary tissue. The surgical approach can involve removal of one or both chains of nipples, mammary glands, and underlying tissue, depending on the extent of disease and the surgeon’s recommendations.
A more aggressive surgical approach involving bilateral mastectomy (removal of both mammary chains) appears to provide better outcomes, even in cases where lymph nodes are metastatic. This approach removes the primary source of tumor cells and may reduce the risk of disease recurrence or progression.
Chemotherapy
The role of adjuvant chemotherapy (chemotherapy given after surgery) remains controversial in feline mammary cancer. Currently, no studies have definitively shown that chemotherapy significantly extends survival time in cats with mammary tumors. However, if cancer has spread throughout the cat’s body, treatment would center on chemotherapy to manage systemic disease. The decision to pursue chemotherapy should be made in consultation with a veterinary oncologist, weighing potential benefits against quality of life considerations.
Prevention Strategies
Early Spaying
The most effective prevention strategy is early spaying (ovariohysterectomy) before six months of age. This procedure dramatically reduces the risk of mammary tumor development, with protected rates of 91% when performed before six months and 86% when performed between seven and twelve months. Even spaying at any age results in a 40% to 60% reduced risk compared to intact cats, though the benefit diminishes significantly after two years of age.
Avoiding Exogenous Hormones
Cat owners should discuss the risks and benefits of hormone-based treatments with their veterinarian, as exogenous progestins and combination hormone therapies significantly increase mammary tumor risk.
Regular Physical Examinations
Regular veterinary examinations, particularly in older female cats, allow for early detection of mammary tumors when they are smaller and have a better prognosis.
Frequently Asked Questions
Q: How common are mammary tumors in cats?
A: Mammary tumors are among the third most common cancers in cats. They are particularly prevalent in intact female cats and become increasingly common with age, typically affecting cats over ten years old.
Q: Can male cats develop mammary tumors?
A: Male cats rarely develop mammary tumors, though it is possible, particularly in intact males or those exposed to exogenous hormones. The overwhelming majority of cases occur in female cats.
Q: What is the survival rate for cats with mammary tumors?
A: Survival rates depend heavily on tumor stage and size at diagnosis. Cats with tumors smaller than two centimeters have very good survival chances of three years or more. However, cats with stage IV disease (distant metastasis) have median survival times of only about 44 days without treatment.
Q: Is spaying always protective against mammary tumors?
A: Spaying is highly protective when performed early in life. Cats spayed before six months have a 91% decreased risk, while those spayed between seven and twelve months have an 86% decreased risk. However, spaying after two years of age provides minimal protection.
Q: What should I do if I find a lump in my cat’s breast tissue?
A: Schedule a veterinary examination immediately. Early detection significantly improves prognosis and treatment outcomes. Your veterinarian will perform a physical examination and recommend appropriate diagnostic tests if needed.
References
- Mammary Tumors in Cats – Reproductive System — Merck Veterinary Manual. 2024. https://www.merckvetmanual.com/reproductive-system/mammary-tumors-in-cats/mammary-tumors-in-cats
- Mammary Tumors in Cats — VCA Animal Hospitals. 2024. https://vcahospitals.com/know-your-pet/mammary-tumors-in-cats
- Mammary Tumours in the Cat: Size matters, so early intervention — National Center for Biotechnology Information (NCBI), PMC. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC10816587/
- Medical Oncology: Feline Mammary Tumors — North Carolina State University College of Veterinary Medicine. 2024. https://hospital.cvm.ncsu.edu/services/small-animals/cancer-oncology/oncology/medical-oncology-feline-mammary-tumors/
- Mammary Tumors — Cornell University College of Veterinary Medicine, Feline Health Center. 2024. https://www.vet.cornell.edu/departments-centers-and-institutes/cornell-feline-health-center/health-information/feline-health-topics/mammary-tumors
- Mammary Tumors – Feline — Veterinary Surgical Society and Orthopedic (VSSO). 2024. https://vsso.org/mammary-tumors-feline
Read full bio of Sneha Tete










